Last reviewed · How we verify
Post-Operative Nausea and Vomiting
Approved treatments
- Droleptan · Clinique Saint Jean, France
- GRAN® · EVIVE Biotechnology
- Anzemet · Validus Pharms
- Inapsine · Rising
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Post-Operative Nausea and Vomiting patent landscape — cliff calendar, originator estates, attackable patents
- Post-Operative Nausea and Vomiting treatment landscape brief
- Post-Operative Nausea and Vomiting treatment updates RSS
Frequently asked questions about Post-Operative Nausea and Vomiting
What drugs treat Post-Operative Nausea and Vomiting?
Tracked treatments include Droleptan, GRAN®, Anzemet, Inapsine.
What is the treatment for Post-Operative Nausea and Vomiting?
Standard treatment for Post-Operative Nausea and Vomiting includes Droleptan, GRAN®, Anzemet, Inapsine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Post-Operative Nausea and Vomiting patent cliff · Post-Operative Nausea and Vomiting CI report
- Treatment: Droleptan · Clinique Saint Jean, France
- Treatment: GRAN® · EVIVE Biotechnology
- Treatment: Anzemet · Validus Pharms
- Treatment: Inapsine · Rising
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing